Press Releases

02.27.2020

Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer

02.27.2020

Mylan and Pfizer Finalize Appointments to Viatris Board of Directors

02.25.2020

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

02.20.2020

Montis Biosciences launched with €8,4 million seed financing and a novel approach to immune-oncology

02.18.2020

European Commission Approves VYNDAQEL®, the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

02.11.2020

XTANDI® (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3 PROSPER Trial of Patients with nmCRPC

01.31.2020

Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCE™ (rituximab)

01.28.2020

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS

01.23.2020

Pfizer Vaccines Launches Global Centers of Excellence Network to Conduct Real-World Research on Vaccine-Preventable Diseases Affecting Adults

01.23.2020

Pfizer’s Greenstone and Digital Men’s Health Clinic Roman Collaborate to Offer Patients Remote Access to the Only FDA-Approved Authorized Generic Version of Viagra® (sildenafil citrate)

01.14.2020

Insilico enters into research collaboration with Pfizer Inc. to explore novel data and artificial intelligence system for potential therapeutic targets

01.13.2020

Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimer’s Disease and Parkinson’s Disease from Pfizer Inc.